Related Experiment Video
Updated: Jul 19, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Hope and schizophrenia: an integrative review
J Kylmä1, T Juvakka, M Nikkonen
1University of Kuopio, Department of Nursing Science, Kuopio, Finland. jari.kylma@uku.fi
Journal of Psychiatric and Mental Health Nursing
|November 8, 2006
Summary
Research on hope and schizophrenia is limited, despite its importance for patients, families, and staff. More studies are needed to understand hope
Area of Science:
- Psychiatry and Mental Health Research
- Psychological Well-being in Chronic Illness
Background:
- Hope is recognized as a crucial element in the recovery and management of schizophrenia.
- Existing literature underscores the significance of hope for individuals with schizophrenia, their support networks, and healthcare professionals.
Purpose of the Study:
- To review and synthesize the current body of research on the role and impact of hope in schizophrenia.
- To identify research gaps and advocate for further investigation into hope-related interventions and outcomes in schizophrenia care.
Main Methods:
- Systematic literature search using CINAHL and PubMed databases with keywords 'hope' and 'schizophrenia'.
- Content analysis of 17 peer-reviewed articles focusing on hope in schizophrenia, examining populations, data collection methods, and research themes.
- Inclusion of research articles specifically addressing individuals with schizophrenia, their significant others, and healthcare staff.
Main Results:
- The reviewed research predominantly focused on individuals with schizophrenia (n=8), followed by significant others (n=4) and staff (n=2).
- Interviews (n=9) and questionnaires (n=8) were the most common data collection methods, with a majority of studies employing quantitative approaches (n=9).
- Key themes identified include factors influencing hope in patients, perspectives of significant others, staff hopefulness, and the evaluation of hope-instilling interventions.
Conclusions:
- Despite the acknowledged importance of hope in schizophrenia, the existing research evidence is notably scant and limited.
- Hope is a vital factor for patients, their families, and healthcare providers involved in schizophrenia care.
- Further research is essential to comprehensively understand and leverage the role of hope in improving outcomes for individuals with schizophrenia.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...